Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit

GlobeNewswire January 21, 2021

Diagnos (TSXV:ADK) successfully completes ISO 13485 / MDSAP audit

Brieanna McCutcheon  January 21, 2021

DIAGNOS (TSXV:ADK) announces three-year AI partnership with University of Montreal hospital

Simon Druker  January 19, 2021

DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

GlobeNewswire January 19, 2021

Diagnos (TSXV:ADK) forms overseas partnership to help diabetic patients

Brieanna McCutcheon  January 14, 2021

DIAGNOS Announces Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients

GlobeNewswire January 14, 2021

DIAGNOS Provides Market Activity Update

GlobeNewswire January 5, 2021

DIAGNOS Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al-Mutairi for his Assignment as Secretary General of the Council of Private Associations of the Kingdom

GlobeNewswire November 12, 2020

9071-8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc.

GlobeNewswire November 5, 2020

DIAGNOS Announces Stock Warrants Term Extension

GlobeNewswire October 7, 2020

Mexico's Largest Optical Retailer to Use DIAGNOS' AI Technology to Detect Early Stage Blindness

GlobeNewswire October 6, 2020

DIAGNOS Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors

GlobeNewswire September 28, 2020

DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California

GlobeNewswire September 15, 2020

DIAGNOS Receives $2,000,000 Assistance from Quebec

GlobeNewswire September 8, 2020

DIAGNOS Announces Annual General Meeting of Shareholders Date and Attendance Special Measures

GlobeNewswire August 26, 2020

DIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine Centre

GlobeNewswire July 14, 2020

DIAGNOS Announces that its Client in California, the Chaparral Medical Group of Clinics, is Reopening the Screening Services for Diabetic Retinopathy after the COVID-19 Shutdown

GlobeNewswire July 7, 2020

DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program

GlobeNewswire April 27, 2020

DIAGNOS Announces Stock Options Grant

GlobeNewswire March 27, 2020

DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the "US White House - Call to Action" to Analyse and Transform COVID-19 Data into Clinical Knowledge

GlobeNewswire March 25, 2020